Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
WELL Health Technologies Corp. is a publicly traded digital health company focused on consolidating and modernizing healthcare delivery through technology-enabled services. The company operates primarily in the digital healthcare, health services, and health information technology industries, with a strategy centered on supporting physicians and healthcare providers rather than replacing them. Its core activities span outpatient clinical care, telehealth, electronic medical records, and specialized healthcare services, positioning the company as a hybrid operator of both healthcare assets and healthcare technology platforms.
Founded in 2010 in Canada, the company initially focused on electronic medical records and gradually expanded through acquisitions into clinical operations and virtual care. Over time, WELL Health evolved into a diversified healthcare platform with recurring revenue streams, emphasizing scale, interoperability, and physician-centric solutions. Its strategy leverages consolidation in fragmented healthcare markets and cross-selling of technology and services across its owned and affiliated clinics.
Business Operations
WELL Health generates revenue through several major operating segments, including Patient Services, Digital Health Solutions, and Specialized Healthcare Services. Patient Services encompasses owned and operated outpatient medical clinics and allied health practices, while Digital Health Solutions includes electronic medical records, virtual care platforms, billing, cybersecurity, and practice management tools. Specialized Healthcare Services consist of niche, high-demand clinical services such as gastroenterology, anesthesia, and diagnostics, primarily delivered through subsidiary platforms.
The company operates both domestically and internationally, with significant operations in Canada and the United States. It controls a broad portfolio of healthcare technologies, clinical assets, and service platforms through wholly owned subsidiaries and majority-controlled entities. WELL Health has pursued partnerships with physician groups and healthcare operators to integrate its technology stack into real-world clinical workflows, reinforcing recurring software and services revenue alongside clinical income.
Strategic Position & Investments
WELL Health’s strategic direction emphasizes disciplined acquisition-led growth, platform integration, and organic expansion within existing assets. The company has made multiple acquisitions to strengthen its presence in outpatient clinics, virtual care, and healthcare software, including CRH Medical Corporation, Circle Medical, and MyHealth Partners, which expanded its U.S. footprint and specialized services capabilities. These investments support its goal of becoming a leading owner-operator of technology-enabled healthcare assets.
The company also invests in emerging healthcare technologies such as cybersecurity for healthcare providers, data interoperability, and AI-enabled clinical and administrative tools. Its portfolio of subsidiaries allows it to test and deploy innovations internally before offering them externally to third-party providers. This integrated model is designed to improve provider efficiency while generating diversified and recurring revenue streams.
Geographic Footprint
WELL Health is headquartered in Vancouver, Canada, and maintains a substantial operational presence across Canada and the United States. In Canada, the company operates one of the largest networks of outpatient medical clinics and serves thousands of healthcare providers through its digital platforms. Its U.S. operations are concentrated in key healthcare markets, including California, Florida, and the Northeastern United States, primarily through specialized clinical services and technology-enabled practices.
Beyond North America, the company has limited but growing international exposure through technology licensing and service relationships. While the majority of revenue is derived from North American operations, WELL Health’s platform-based model provides optionality for future international expansion without heavy capital deployment.
Leadership & Governance
WELL Health was founded by Hamed Shahbazi, who continues to play a central role in shaping the company’s long-term strategy and acquisition-driven growth model. The leadership team emphasizes physician enablement, operational discipline, and capital allocation aligned with sustainable cash flow generation. Governance is overseen by an independent board with experience in healthcare, technology, and public markets.
Key executives include:
- Hamed Shahbazi – Founder and Chief Executive Officer
- Eva Fong – Chief Financial Officer
- Dr. Brian Affleck – Chief Medical Officer
- James Lee – Chief Operating Officer
- Blake Locke – Chief Legal Officer and Corporate Secretary
The leadership philosophy centers on combining clinical credibility with scalable technology, aiming to modernize healthcare delivery while maintaining practitioner autonomy and patient trust.